Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells. 2019

Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.

Aims: Berberine (BBR) improves beta-cell function in Type 2 diabetes (T2D) because of its anti-apoptotic activity, and our laboratory developed a new preparation named Huang-Gui Solid Dispersion (HGSD) to improve the oral bioavailability of BBR. However, the mechanism by which BBR inhibits beta-cell apoptosis is unclear. We hypothesized that the Group VIA Ca2+-Independent Phospholipase A2 (iPLA2β)/Cardiolipin(CL)/Opa1 signaling pathway could exert a protective role in T2D by regulating beta-cell apoptosis and that HGSD could inhibit β-cell apoptosis through iPLA2β/CL/Opa1 upregulation. Methods: We examined how iPLA2β and BBR regulated apoptosis and insulin secretion through CL/Opa1 in vivo and in vitro. In in vitro studies, we developed Palmitate(PA)-induced apoptotic cell death model in mouse insulinoma cells (MIN6). iPLA2β overexpression and silencing technology were used to examine how the iPLA2β/CL/Opa1 interaction may play an important role in BBR treatment. In in vivo studies, db/db mice were used as a diabetic animal model. The pancreatic islet function and morphology, beta-cell apoptosis and mitochondrial injury were examined to explore the effects of HGSD. The expression of iPLA2β/CL/Opa1 was measured to explore whether the signaling pathway was damaged in T2D and was involved in HGSD treatment. Results: The overexpression of iPLA2β and BBR treatment significantly attenuated Palmitate- induced mitochondrial injury and apoptotic death compared with Palmitate-treated MIN6 cell. In addition, iPLA2β silencing could simultaneously partly abolish the anti-apoptotic effect of BBR and decrease CL/Opa1 signaling in MIN6 cells. Moreover, HGSD treatment significantly decreased beta-cell apoptosis and resulted in the upregulation of iPLA2β/CL/Opa1 compared to those of the db/db mice. Conclusion: The results indicated that the regulation of iPLA2β/CL/Opa1 by HGSD may prevent beta-cell apoptosis and may improve islet beta-cell function in Type 2 diabetic mice and in palmitate-treated MIN6 cells.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008516 Medicine, Chinese Traditional A system of traditional medicine which is based on the beliefs and practices of the Chinese culture. Chinese Medicine, Traditional,Chung I Hsueh,Traditional Medicine, Chinese,Zhong Yi Xue,Chinese Traditional Medicine,Traditional Chinese Medicine,Traditional Tongue Assessment,Traditional Tongue Diagnosis,Hsueh, Chung I,Tongue Assessment, Traditional,Tongue Diagnoses, Traditional,Tongue Diagnosis, Traditional,Traditional Tongue Assessments,Traditional Tongue Diagnoses
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010168 Palmitates Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid. Hexadecanoates,Palmitate
D002308 Cardiolipins Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS. Cardiolipin,Diphosphatidylglycerol,Diphosphatidylglycerols
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus

Related Publications

Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
January 2016, Journal of diabetes research,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
June 2020, Chinese journal of natural medicines,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
October 2022, Acta biochimica et biophysica Sinica,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
November 2013, Endocrinology,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
April 2012, Journal of cellular biochemistry,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
December 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
May 2014, The Journal of biological chemistry,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
March 2024, Scientific reports,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
November 2015, Apoptosis : an international journal on programmed cell death,
Junnan Li, and Hongwei Du, and Meishuang Zhang, and Zhi Zhang, and Fei Teng, and Yali Zhao, and Wenyou Zhang, and Yang Yu, and Linjing Feng, and Xinming Cui, and Ming Zhang, and Tzongshi Lu, and Fengying Guan, and Li Chen
January 2021, Frontiers in pharmacology,
Copied contents to your clipboard!